Global Antibiotic Drugs Market (2024 Edition): Analysis By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Others), Spectrum (Broad, Narrow), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)
Azoth Analytics has released a research report titled "Global Antibiotic Drugs Market (2024 Edition)" which provides a complete analysis of the global Antibiotic Drugs industry in terms of market segmentation By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Others), Spectrum (Broad, Narrow), By Indication (Pneumonia, Meningitis, Gastrointestinal infections, Urinary Tract Infections, Other Indications), By Region and By Country for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.
The research study also assesses market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution. During the forecast period, 2024-2029, the Global Antibiotic Drugs market is expected to grow at a CAGR of 4.7%
The Global Antibiotic Drugs Market is expected to generate USD 73.92 Billion by the end of 2029, up from USD 50.41 Billion in 2022. The antibiotic drugs market has witnessed steady growth over the years. The increasing prevalence of bacterial infections, coupled with the perpetual evolution of antibiotic resistance, propels the demand for innovative antibiotic therapies. The market is characterized by a diverse range of antibiotics, including Cephalosporins, fluoroquinolones, macrolides, and tetracyclines, each playing a distinct role in addressing bacterial infections.
The increased recognition of the significance of prompt and efficient antibiotic treatment within the healthcare community and the general populace catalyse increased demand. Programs advocating for responsible antibiotic usage and providing education about the repercussions of antibiotic resistance play a crucial role in influencing market trends. The escalating threat of antibiotic resistance has prompted concerted global efforts to develop new antibiotics and preserve the effectiveness of existing ones. Collaborative initiatives between pharmaceutical companies, research institutions, and governmental bodies aim to address this critical healthcare challenge.
Scope of the Report
The report analyses the Antibiotic Drugs Market by Value (USD Billion).
The report presents the analysis of the Antibiotic Drugs Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
The report analyses the Antibiotic Drugs Market by Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Other Drug Classes).
The report analyses the Antibiotic Drugs Market By Spectrum (Broad Spectrum, Narrow Spectrum)
The report analyses the Antibiotic Drugs Market By Indication (Pneumonia, Meningitis, Gastrointestinal infections, Urinary Tract Infections, Other Indications).
The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by Drug Class, By Spectrum & By Indication.
Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.
The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Abbott Laboratories, Johnson & Johnson, Pfizer, GSK PLC, Novartis AG, Roche Holding AG, Bayer AG, Merck & Co., Inc., Viatris Inc. and Cipla.
Table of Contents
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Strategic Recommendations
3. Global Antibiotic Drugs Market: Historic and Forecast (2019-2029)
3.1 Global Prevalence of Infectious Diseases, 2019
3.2 Global Incidence of Infectious Diseases, 2019
3.3 Top 10 most prescribed outpatient antibiotics
3.4 Global Antibiotic Drugs Market: Dashboard
3.5 Global Antibiotic Drugs Market: Market Value Assessment, 2019-2029 (USD Billion)
3.6 Impact of COVID-19 on Global Antibiotic Drugs Market
3.7 Global Antibiotic Drugs Market Segmentation: By Drug Class
3.7.1 Global Antibiotic Drugs Market, By Drug Class Overview
3.7.2 Global Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.3 Global Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.4 Global Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.5 Global Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.6 Global Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
3.8 Global Antibiotic Drugs Market Segmentation: By Spectrum
3.8.1 Global Antibiotic Drugs Market, By Spectrum Overview
3.8.2 Global Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.3 Global Antibiotic Drugs Market Size, By Narrow Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
3.9 Global Antibiotic Drugs Market Segmentation: By Indication
3.9.1 Global Antibiotic Drugs Market, By Indication Overview
3.9.2 Global Antibiotic Drugs Market Size, By Pneumonia By Value, 2019H-2029F (USD Billion & CAGR)
3.9.3 Global Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
3.9.4 Global Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
3.9.5 Global Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)
3.9.6 Global Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)
4. Global Antibiotic Drugs Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Antibiotic Drugs Market: Historic and Forecast (2019-2029)